• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-DIRAS2

DIRAS2 Polyclonal Antibody for WB, IF/ICC, FC (Intra), IP, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IF/ICC, FC (Intra), IP, ELISA

Conjugaison

Non conjugué

Publications(5)

N° de cat : 15557-1-AP

Synonymes

GTP binding protein Di Ras2, GTP-binding protein Di-Ras2



Applications testées

Résultats positifs en WBtissu cérébral humain, cellules HeLa, tissu cérébral de rat, tissu cérébral de souris
Résultats positifs en IPtissu cérébral de souris
Résultats positifs en IF/ICCcellules HeLa
Résultats positifs en FC (Intra)cellules HeLa,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:500-1:3000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

15557-1-AP cible DIRAS2 dans les applications de WB, IF/ICC, FC (Intra), IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Réactivité citéeHumain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène DIRAS2 Protéine recombinante Ag7926
Nom complet DIRAS family, GTP-binding RAS-like 2
Masse moléculaire calculée 22 kDa
Poids moléculaire observé 22 kDa
Numéro d’acquisition GenBankBC008065
Symbole du gène DIRAS2
Identification du gène (NCBI) 54769
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

GTP-binding protein Di-Ras2 (DIRAS2) is a member of the Ras-related small G-protein family. DIRAS2 regulated the phosphorylation of downstream effector proteins and activated the RAS/mitogen-activated protein kinase (MAPK) signaling pathway (PMID: 3216131). DIRAS2 interacted with 26S proteasome non-ATPase regulatory subunit 2, which facilitates the degradation of DIRAS2 in a proteasome-mediated way. DIRAS2 blocked nuclear factor kappa light-chain enhancer of activated B-cell (NF-κB) signaling pathways, inducing G0/G1 arrest. DIRAS2 inhibited CRC cell proliferation and affected cell-cycle protein expression (PMID: 35173535). DIRAS2 was proved to be an oncogene that activated the RAS-MAPK pathway to induce cell proliferation and metastasis in renal cell cancer (PMID: 3216131). DIRAS2 also shows its activity as a tumor-suppressor gene to induce autophagic cell death via modulating nuclear localization FOXO3/FOXO3A and TFEB (PMID: 29368982).

Protocole

Product Specific Protocols
WB protocol for DIRAS2 antibody 15557-1-APDownload protocol
IF protocol for DIRAS2 antibody 15557-1-APDownload protocol
IP protocol for DIRAS2 antibody 15557-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB,IP

Oncogene

Di-Ras2 promotes renal cell carcinoma formation by activating the mitogen-activated protein kinase pathway in the absence of von Hippel-Lindau protein.

Authors - Hanyu Rao
  • KD Validated
humanWB

Cancers (Basel)

Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas.

Authors - Tanja Rothhammer-Hampl
mouse,humanWB,IF

J Neural Transm (Vienna)

Expression of the ADHD candidate gene Diras2 in the brain.

Authors - Lena Grünewald
humanWB

Dev Cell

The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells

Authors - Yu Chang
humanWB

Int J Biol Sci

eNAMPT/Ac-STAT3/DIRAS2 Axis Promotes Development and Cancer Stemness in Triple-Negative Breast Cancer by Enhancing Cytokine Crosstalk Between Tumor-Associated Macrophages and Cancer Cells

Authors - Lifen Zhang
  • KD Validated
{{ptg:RelatedPrimaryAntibodies}}